×
Back to Agenda
Collaborative Frameworks and Public Private Partnerships as Drivers of Innovation
Session Chair(s)
Corinne de Vries, PhD, MA, MSc
EMA liaison official to the US FDA
European Medicines Agency, Netherlands
A condensed overview of the current state of play when it comes to PPP s from an EU perspective and their key role in bringing together the latest research and cutting-edge technology to boost innovation and entrepreneurship in the pharmaceutical sector, to meet the challenges faced by patients and society as a whole.
Speaker(s)
Accelerating Innovation through Public Private Partnerships: IMI as an Example
Pierre Meulien, PhD
Innovative Medicines Initiative (IMI), Belgium
Executive Director
Advancing Innovation with Novel Methodologies - C-Path’s PPP Approach to Achieving Regulatory Acceptance
Martha Ann Brumfield, PhD
Critical Path Institute, United States
President and Chief Executive Officer
The IMI SAFE-T Consortium: Engaging with Regulators to Enhance Success and Opportunities of Public Private Partnerships
Gerd Kullak-Ublick
Novartis, Switzerland
Global Head, Mechanistic Safety, Chief Medical Office and Patient Safety
Have an account?